COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022

We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in elderly people in Portugal between May and July 2022. In ≥ 80 year-olds, the second booster dose VE was 81% (95% CI: 75–85) and 82% (95% CI: 77–85), respectively, against COVID-19-related hospitalisation and death. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kislaya, Irina, Machado, Ausenda, Magalhães, Sarah, Rodrigues, Ana Paula, Franco, Rafael, Leite, Pedro Pinto, Dias, Carlos Matias, Nunes, Baltazar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479470/
https://www.ncbi.nlm.nih.gov/pubmed/36111555
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.37.2200697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479470/
https://www.ncbi.nlm.nih.gov/pubmed/36111555
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.37.2200697

Ejemplares similares